Moisture curable compositions
US-2024400829-A1 · Dec 5, 2024 · US
US9797897B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9797897-B2 |
| Application number | US-201314388508-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 15, 2013 |
| Priority date | Mar 26, 2012 |
| Publication date | Oct 24, 2017 |
| Grant date | Oct 24, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Acoustically responsive particles and methods are provided for their use. Methods are provided for making and using tunable, monodisperse acoustically responsive particles and negative contrast acoustic particles, wherein the particles can contain a functional group available for covalent modification.
Opening claim text (preview).
What is claimed is: 1. A method for synthesizing elastomeric negative contrast acoustic particles having a functional vinyl group available for covalent modification, the method comprising: emulsifying an elastomer pre-polymer comprising the functional vinyl group with a catalyst in the presence of a surfactant under conditions sufficient to produce emulsion droplets; curing the emulsion droplets under conditions sufficient to form stable elastomeric negative acoustic contrast particles that have the functional vinyl group available for covalent modification; and contacting the negative acoustic contrast particles with biotin-PEG-tetrafluorophenyl azide under conditions sufficient to covalently modify the available vinyl functional group with biotin for binding to a target of interest. 2. The method of claim 1 , wherein the elastomer pre-polymer comprises a silicone material. 3. The method of claim 1 , wherein the elastomer pre-polymer comprises polyvinylmethylsiloxane (PVMS). 4. The method of claim 1 , wherein the surfactant is a nonionic triblock copolymer surfactant. 5. The method of claim 4 , wherein the nonionic triblock copolymer surfactant has greater than 50 end groups of polyethylene oxide (PEO). 6. The method of claim 5 , wherein the nonionic triblock copolymer surfactant has a hydrophile-lipophile (HLB) value greater than 24. 7. The method of claim 1 , wherein the target of interest comprises one of a cell, a protein, a receptor, an antibody, an antigen, a drug, virus, nucleic acid, a polysaccharide or a metabolite.
Polysiloxanes · CPC title
by sorbent column, particles or resin strip {, i.e. sorbent materials} · CPC title
containing silicon · CPC title
Polysiloxanes · CPC title
with a particulate label, e.g. coloured latex · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.